Evidence map›Paper›PMID 40334268›Full record

SynthesisJournal of medical Internet research2025

Telehealth Interventions in Pharmacy Practice: Systematic Review of Reviews and Recommendations.

Rachel Lai Kay Chong, Andrew Siang Ee Chan, Crystal Min Siu Chua, Yi Feng Lai

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rachel Lai Kay Chong *NUS Pharmacy and Pharmaceutical Sciences, Singapore, Singapore.ORCID 0009-0006-5199-7228
Andrew Siang Ee Chan *NUS Pharmacy and Pharmaceutical Sciences, Singapore, Singapore.ORCID 0009-0007-7365-9219
Crystal Min Siu Chua *MOH Office for Healthcare Transformation, Singapore, Singapore.ORCID 0000-0001-6057-3247
Yi Feng LaiMOH Office for Healthcare Transformation, Singapore, Singapore.ORCID 0000-0002-0475-7479

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPharmaceutical care has expanded, with telehealth playing a key role, especially during the COVID-19 pandemic. Despite global growth, existing reviews focus on specific settings or conditions, highlighting the need for broader research on public health topics and comparative studies to evaluate the effectiveness, preferences, and cost of telehealth interventions in pharmacy practice.

objectiveThe aim of this study was to unify existing literature on the impact of telehealth on future pharmacy practice and to analyze those already implemented in current pharmacy practice, with the objective of providing recommendations.

methodsThe PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) framework was used to guide this review. In total, 4 databases were searched for relevant studies: PubMed, CINAHL, Web of Science, and Cochrane Library. Title, abstract, and full-text screening was performed, and 18 reviews met the selection criteria. The search period was from August 1, 2012, to December 22, 2024. The quality of the reviews was assessed using a 5-point Likert scale and a GRADE-CERQual scale.

resultsBased on the identified reviews, telehealth interventions were categorized into teleconsultation, telemonitoring, telecollaboration, and telesupport. Teleconsultation was the most frequently used. Telephones were most common in teleconsultations and telemonitoring, while mobile, web, or computer applications were most frequent in telesupport. A combination of methods was most used to facilitate telecollaboration, such as telephone, fax, electronic messaging, shared electronic records, and videoconferencing. The identified reviews were evaluated by health outcomes, hospital readmission rates, patient safety, adherence, satisfaction, pharmacist shortage, and quality and access to care. The use of telehealth in pharmacy has generally seen an improvement in overall outcomes compared to traditional pharmacy practice. Our results show a strong push to integrate telehealth into future pharmacy practice, with the United States leading the way in adoption, demonstrating increased care access, quality, and patient safety. In Singapore, telephone consultations have been commonly used in hospitals, though community settings lack widespread adoption. However, the growing digital literacy of older adults and innovations like chatbots and telemonitoring present opportunities to expand telehealth services. To align with this shift, pharmacy education should invest in enhancing formative training by incorporating telehealth training, ensuring future pharmacists are prepared for this evolving practice, applicable to regions with similar contexts.

conclusionsTelehealth has shown promise in improving overall outcomes in pharmacy practice. While many countries have made strides, particularly in hospital settings, there remains an opportunity for greater adoption in community health care, driven by innovations like telemonitoring and digital literacy among older adults. The findings from this study can be used to inform future implementation of telehealth interventions in pharmacy in Singapore and other regions or cities with similar contexts.

Indexed as

Pharmaceutical ServicesTelemedicineHumansReview Literature as Topicdatabaseelectronic messagingelectronic recordsfaxinnovationInterventionliteraturemeta-analysispharmacypharmacy practicerecommendationsserviceSingaporesystematic reviewsystematic review of reviewstelecollaborationteleconsultationtelehealthtelehealth interventionstelemonitoringtelepharmacytelephonetelesupportvideo conferencing

Identifiers

PMID40334268
PMCPMC12096025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.